Facilitated By

San Antonio Medical Foundation

News

  • Ultragenyx: Q2 Earnings Snapshot - San Antonio Express-News

    The biotechnology company posted revenue of $166.5 million in the ... San Antonio Mayor Gina Ortiz Jones called it “unfortunate” that video ...

  • Capital Square Acquires Active Adult Build-For-Rent Community Near San Antonio, Texas ...

    Biotechnology · Clinical Trials ... Capital Square Acquires Active Adult Build-For-Rent Community Near San Antonio, Texas, for New DST Offering.

  • East Bay's Xoma adds two more biotechs to its portfolio - San Francisco Business Times

    San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay ... Biotech companies' pain could be a longtime East Bay player's gain.

  • BTIG Remains a Buy on Ardelyx (ARDX) With a $14 PT - MSN

    (NASDAQ:ARDX) is one of the best biotech penny stocks to buy right now. ... New revelations stir controversy in San Antonio Aquarium octopus scandal.

  • Amgen Posts Higher Profit, Revenue On Sales Growth Among Products - MSN

    Should You Leave Assets to Your Children in a Trust or as a Gift? Sponsored. New revelations stir controversy in San Antonio Aquarium octopus scandal.